SBC Medical Group (SBC) Stock Price, News & Analysis

Company Overview

SBC Medical Group Holdings provides management and support services to medical institutions, with a focus on clinics offering aesthetic medicine. Its services include support for clinic operations, marketing, staff training, procurement and customer service, allowing affiliated medical providers to focus on patient care.

The group is associated with the Shonan Beauty Clinic brand and a broader network of clinics offering services such as cosmetic surgery and dermatology. Its business is centered primarily in Japan, where it supports the operations and growth of affiliated medical institutions.

Key Stats

• Today's Range: $6.07 to $7.18
• 50-Day Range: $4.12 to $5.69
• 52-Week Range: $2.78 to $7.18
• Volume: 1.32 million shs
• Average Volume: 128,512 shs
• Market Capitalization: $750.81 million
• P/E Ratio: 15.44
• Dividend Yield: N/A
• Price Target: $8.00
• Consensus Rating: Moderate Buy

SBC Medical Group Stock Analysis - MarketRank™

SBC Medical Group scored higher than 68% of companies evaluated by MarketBeat, and ranked 130th out of 892 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.8 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

SBC Medical Group has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on no strong buy ratings, 1 buy rating, 1 hold rating, and no sell ratings.

Upside Potential

SBC Medical Group has a consensus price target of $8.00, representing about 16.4% upside from its current price of $6.87.

Amount of Analyst Coverage

SBC Medical Group has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 3.1 / 5
• Proj. Earnings Growth: 18.18%

Earnings Growth

Earnings for SBC Medical Group are expected to grow by 18.18% in the coming year, from $0.44 to $0.52 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of SBC Medical Group is 14.65, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 26.39.

Price to Earnings Ratio vs. Sector

The P/E ratio of SBC Medical Group is 14.65, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 34.46.

Price to Earnings Growth Ratio

SBC Medical Group has a PEG Ratio of 2.36. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

SBC Medical Group has a P/B Ratio of 2.67. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

4.47% of the float of SBC Medical Group has been sold short.

Short Interest Ratio / Days to Cover

SBC Medical Group has a short interest ratio ("days to cover") of 4.57.

Change versus previous month

Short interest in SBC Medical Group has recently increased by 11.97%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

SBC Medical Group does not currently pay a dividend.

Dividend Growth

SBC Medical Group does not have a long track record of dividend growth.

News and Social Media

• Score: 2.8 / 5
• News Sentiment: 0.46

News Sentiment

SBC Medical Group has a news sentiment score of 0.46. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.56 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 13 news articles for SBC Medical Group this week, compared to 3 articles on an average week.

Search Interest

4 people have searched for SBC on MarketBeat in the last 30 days.

Company Ownership

• Score: 1.4 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, SBC Medical Group insiders have not sold or bought any company stock.

Percentage Held by Insiders

81.70% of the stock of SBC Medical Group is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

60.82% of the stock of SBC Medical Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Today: 11/13/2026
• Last Earnings: 11/13/2026
• Next Earnings (Estimated): 11/13/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Providers & Services
• Sub-Industry: Healthcare Services
• Current Symbol: NASDAQ:SBC
• Previous Symbol: NASDAQ:SBC
• CIK: 1930313
• Web: sbc-holdings.com
• Phone: (949) 593-0250
• Fax: N/A
• Employees: 863
• Year Founded: N/A

Price Target and Rating

• Average Price Target for SBC Medical Group: $8.00
• High Price Target: $8.00
• Low Price Target: $8.00
• Potential Upside/Downside: +10.7%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.50
• Research Coverage: 2 Analysts

Profitability

• EPS (Trailing Twelve Months): $0.47
• Trailing P/E Ratio: 15.32
• Forward P/E Ratio: 13.89
• P/E Growth: 2.36
• Net Income: $50.99 million
• Net Margins: 27.99%
• Pretax Margin: 43.09%
• Return on Equity: 18.47%
• Return on Assets: 13.10%

Debt

• Debt-to-Equity Ratio: 0.09
• Current Ratio: 3.31
• Quick Ratio: 3.27

Sales & Book Value

• Annual Sales: $173.61 million
• Price / Sales: 4.28
• Cash Flow: $0.72 per share
• Price / Cash Flow: 10.02
• Book Value: $2.57 per share
• Price / Book: 2.81

Miscellaneous

• Outstanding Shares: 102,850,000
• Free Float: 18,821,000
• Market Cap: $743.09 million
• Optionable: Optionable
• Beta: 0.52